India to United States: Dapsone Export Trade Route
India has recorded 126 verified shipments of Dapsone exported to United States, representing a combined trade value of $16.3M USD. This corridor is served by 8 active Indian exporters, with an average shipment value of $129.2K USD. The leading Indian exporter is TORRENT PHARMACEUTICALS LTD, which accounts for 51% of total export value with 26 shipments worth $8.3M USD. On the buying side, TORRENT PHARMA INC is the largest importer in United States with $7.7M USD in purchases. The top 3 suppliers — TORRENT PHARMACEUTICALS LTD, TORRENT PHARMACEUTICALS LIMITED, ALEMBIC PHARMACEUTICALS LIMITED — together control 95% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Dapsone corridor is one of India's established pharmaceutical export routes, with 126 shipments documented worth a combined $16.3M USD. The route is dominated by TORRENT PHARMACEUTICALS LTD, which alone accounts for roughly 51% of all export value, reflecting the consolidated nature of India's dapsone manufacturing sector.
Across 8 active suppliers, the average shipment value stands at $129.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (68%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October–December, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 31.6%, placing it at rank #1 among India's top dapsone export destinations globally.
On the import side, key buyers of Indian dapsone in United States include TORRENT PHARMA INC, TORRENT PHARMA INC,, J. KNIPPER & COMPANY and 16 others. TORRENT PHARMA INC is the single largest importer with 22 shipments valued at $7.7M USD.
Route Characteristics
- Average transit18 days
- Peak seasonQ4
- Primary modeMulti-modal
- Top portCHENNAI AIR CARGO ACC (INMAA4)
Market Position
- Global rank#1
- Annual growth+31.6%
- Demand growth+26.4%
- Regulatory ease68/100
Top 10 Indian Dapsone Exporters to United States
Showing top 10 of 8 Indian suppliers exporting Dapsone to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TORRENT PHARMACEUTICALS LTD Avg $317.4K per shipment | 26 | $8.3M | 50.7% |
| 2 | TORRENT PHARMACEUTICALS LIMITED Avg $413.4K per shipment | 12 | $5.0M | 30.5% |
| 3 | ALEMBIC PHARMACEUTICALS LIMITED Avg $126.0K per shipment | 18 | $2.3M | 13.9% |
| 4 | ENCUBE ETHICALS PRIVATE LIMITED Avg $29.2K per shipment | 17 | $496.5K | 3.1% |
| 5 | ZYDUS LIFESCIENCES LIMITED Avg $46.3K per shipment | 5 | $231.4K | 1.4% |
| 6 | CASPER PHARMA PRIVATE LIMITED Avg $67.3K per shipment | 1 | $67.3K | 0.4% |
| 7 | NOVITIUM LABS PRIVATE LIMITED Avg $27 per shipment | 46 | $1.2K | 0.0% |
| 8 | GENEX PHARMA Avg $31 per shipment | 1 | $31 | 0.0% |
This table shows the top 10 of 8 Indian companies exporting dapsone to United States, ranked by total trade value. The listed exporters are: TORRENT PHARMACEUTICALS LTD, TORRENT PHARMACEUTICALS LIMITED, ALEMBIC PHARMACEUTICALS LIMITED, ENCUBE ETHICALS PRIVATE LIMITED, ZYDUS LIFESCIENCES LIMITED, CASPER PHARMA PRIVATE LIMITED, NOVITIUM LABS PRIVATE LIMITED, GENEX PHARMA. TORRENT PHARMACEUTICALS LTD is the dominant supplier with 26 shipments worth $8.3M USD, giving it a 51% market share. The top 3 suppliers together account for 95% of the total trade value on this route.
Top 10 Dapsone Importers in United States
Showing top 10 of 19 known buyers in United States receiving Dapsone shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian dapsone in United States include TORRENT PHARMA INC, TORRENT PHARMA INC,, J. KNIPPER & COMPANY, TORRENT PHARMA INC C O, J KNIPPER COMPANY, among 19 total buyers. The largest importer is TORRENT PHARMA INC, accounting for $7.7M USD across 22 shipments — representing 47% of all dapsone imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TORRENT PHARMA INC | 22 | $7.7M | 47.0% |
| 2 | TORRENT PHARMA INC, | 11 | $3.8M | 23.4% |
| 3 | J. KNIPPER & COMPANY | 8 | $899.1K | 5.5% |
| 4 | TORRENT PHARMA INC C O | 2 | $752.3K | 4.6% |
| 5 | J KNIPPER COMPANY | 5 | $707.2K | 4.3% |
| 6 | TORRENT PHARMA INC C/O, | 2 | $665.0K | 4.1% |
| 7 | J. KNIPPER & COMPANY, | 5 | $661.5K | 4.1% |
| 8 | TORRENT PHARMA INC CO | 1 | $329.2K | 2.0% |
| 9 | EVERSANA LIFE SCIENCE SERVICES | 5 | $231.4K | 1.4% |
| 10 | DHL - EXEL, INC | 4 | $149.6K | 0.9% |
Showing top 10 of 19 Dapsone importers in United States on this route.
Top 10 Dapsone Formulations Imported by United States
Showing top 10 of 74 product formulations shipped on the India to United States Dapsone route, ranked by trade value
United States imports a wide range of dapsone formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — DAPSONE 7 5 GEL 60GM MAYNE NDC CODE68308 342 60 DAPSONE GEL 7 5 NOS SIZE60 G — accounts for $2.6M USD across 3 shipments. There are 74 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DAPSONE 7 5 GEL 60GM MAYNE NDC CODE68308 342 60 DAPSONE GEL 7 5 NOS SIZE60 G | 3 | $2.6M | 15.9% |
| 2 | DAPSONE GEL,7.5% 60GM NDC CODE 13668-605-05DAPSONE GEL 7.5% NOS=60G | 2 | $2.4M | 14.8% |
| 3 | DAPSONE GEL 7.5%,60GM (NDC CODE13668-605-05)(DAPSONE GEL 7.5%) (NOS=60G) | 1 | $1.4M | 8.5% |
| 4 | DAPSONE GEL 7.5%,60GM (NDC CODE13668-605-05)(DAPSONE GEL 7.5%) (NOS=60G)NOS | 1 | $1.0M | 6.3% |
| 5 | DAPSONE 7.5%, GEL 60GM (MAYNE)(NDC CODE | 1 | $783.3K | 4.8% |
| 6 | DAPSONE 7.5% GEL 60G MAYNE NDC CODE.68308-342-60DAPSONE GEL 7.5% NOS SIZE 60G | 1 | $706.6K | 4.3% |
| 7 | DAPSONE GEL, 7.5%,60GM (NDC CODE13668-6 | 1 | $515.5K | 3.2% |
| 8 | DAPSONE GEL 7 5 60 GM NDC CODE 13668 605 05 DAPSONE GEL 7 5 NOS 60G | 1 | $465.7K | 2.9% |
| 9 | DAPSONE GEL 7.5% (60G PUMP) | 3 | $444.9K | 2.7% |
| 10 | DAPSONE GEL 7.5% 60G PUMP | 1 | $401.4K | 2.5% |
Showing top 10 of 74 Dapsone formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 68% sea for bulk, 17% air for urgent orders.
Top Ports of Origin
CHENNAI AIR CARGO ACC (INMAA4) handles the highest volume with 27 shipments. Transit time averages 18 days by sea.
Market Dynamics
India's dapsone exports to United States are driven primarily by a handful of large-scale manufacturers. TORRENT PHARMACEUTICALS LTD with 26 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — TORRENT PHARMACEUTICALS LTD, TORRENT PHARMACEUTICALS LIMITED, ALEMBIC PHARMACEUTICALS LIMITED — together account for 95% of total trade value on this route. The average shipment value of $129.2K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as dapsone gel,7.5% 60gm ndc code 13668-605-05dapsone gel 7.5% nos=60g and dapsone gel 7.5%,60gm (ndc code13668-605-05)(dapsone gel 7.5%) (nos=60g), suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, TORRENT PHARMA INC is the largest importer with 22 shipments worth $7.7M USD — representing 47% of all dapsone imports from India on this route. A total of 19 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $16.3M
- Avg. Shipment
- $129.2K
- Suppliers
- 8
- Buyers
- 19
- Transit (Sea)
- ~18 days
- Annual Growth
- +31.6%
Reverse Direction
United States → India — Dapsone (Import)Other Dapsone Routes
Unlock the Full India to United States Dapsone Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 126 shipments on this route.
Frequently Asked Questions — India to United States Dapsone Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Dapsone to United States?
The leading Indian exporters of Dapsone to United States are TORRENT PHARMACEUTICALS LTD, TORRENT PHARMACEUTICALS LIMITED, ALEMBIC PHARMACEUTICALS LIMITED. TORRENT PHARMACEUTICALS LTD holds the largest market share at approximately 51% of total trade value on this route.
Q What is the total value of Dapsone exports from India to United States?
India exports Dapsone to United States worth approximately $16.3M USD across 126 recorded shipments. The average value per shipment is $129.2K USD.
Q Which ports does India use to ship Dapsone to United States?
The most active port of origin is CHENNAI AIR CARGO ACC (INMAA4) with 27 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 68% of shipments going by sea and 17% by air.
Q How long does shipping take from India to United States for Dapsone?
The average transit time for Dapsone shipments from India to United States is approximately 18 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to United States Dapsone trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 31.6% with demand growth tracking at 26.4%. The route is ranked #1 among India's top Dapsone export destinations globally.
Q How many suppliers are active on the India to United States Dapsone route?
There are currently 8 active Indian suppliers exporting Dapsone to United States. The market is moderately concentrated with TORRENT PHARMACEUTICALS LTD accounting for 51% of total shipment value.
Q Who are the main importers of Dapsone from India in United States?
The leading importers of Indian Dapsone in United States include TORRENT PHARMA INC, TORRENT PHARMA INC,, J. KNIPPER & COMPANY, TORRENT PHARMA INC C O, J KNIPPER COMPANY. TORRENT PHARMA INC is the largest buyer with 22 shipments worth $7.7M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Dapsone.
- 2.Supplier/Buyer Matching: 8 Indian exporters and 19 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 126 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
126 Verified Shipments
8 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists